Hormonal
In human skeletal muscle disuse atrophy, muscle mass loss is primarily driven by a depression in protein synthesis (both fasted and fed states) rather than an elevation in protein breakdown (proteolysis).
When you immobilize a limb, your muscle shrinks mainly because it stops building protein, not because it actively destroys it. The muscle becomes 'resistant' to the normal building signals from food (amino acids). Therefore, simply trying to stop breakdown (e.g., with anti-catabolic drugs) may be less effective than addressing the failure of synthesis, potentially through mechanical loading or specific nutritional strategies that overcome this 'anabolic resistance', though the paper notes standard amino acid supplementation often fails to rescue this resistance in the short term.
We therefore propose that most of the loss of muscle mass during disuse atrophy can be accounted for by a depression in the rate of protein synthesis. Thus the normal diurnal fasted-to-fed cycle of protein balance is disrupted and, by default, proteolysis becomes dominant but is not enhanced.
Why this rating
Based on dynamic in vivo human measurements (arterial-venous balance, tracer dilution) rather than static animal models or mRNA expression.
Source
Alterations of protein turnover underlying disuse atrophy in human skeletal muscle
Stuart M. Phillips et al. · Journal of Applied Physiology · 2009
DOI 10.1152/japplphysiol.00452.2009
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →